Aprea AB - Product Pipeline Review - 2013

  • October 2013
  • -
  • Global Markets Direct
  • -
  • 22 pages

Aprea AB - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Aprea AB - Product Pipeline Review - 2013” provides data on the Aprea AB’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Aprea AB’s corporate website, SEC filings, investor presentations and featured press releases, both from Aprea AB and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Aprea AB - Brief Aprea AB overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Aprea AB human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Aprea AB with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Aprea AB’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Aprea AB’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Aprea AB in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Aprea AB’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Aprea AB.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Aprea AB and identify potential opportunities in those areas.

Table Of Contents

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Aprea AB Snapshot 4
Aprea AB Overview 4
Key Information 4
Key Facts 4
Aprea AB - Research and Development Overview 5
Key Therapeutic Areas 5
Aprea AB - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Aprea AB - Pipeline Products Glance 9
Aprea AB Clinical Stage Pipeline Products 9
Phase I Products/Combination Treatment Modalities 9
Aprea AB - Early Stage Pipeline Products 10
Discovery Products/Combination Treatment Modalities 10
Aprea AB - Drug Profiles 11
APR-017 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
APR-246 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
APR-246 Analogues 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
Aprea AB - Pipeline Analysis 14
Aprea AB - Pipeline Products by Therapeutic Class 14
Aprea AB - Pipeline Products By Target 15
Aprea AB - Pipeline Products by Route of Administration 16
Aprea AB - Pipeline Products By Mechanism of Action 17
Aprea AB - Recent Pipeline Updates 18
Aprea AB - Dormant Projects 19
Aprea AB - Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
Coverage 21
Secondary Research 21
Primary Research 21
Expert Panel Validation 21
Contact Us 22
Disclaimer 22



List of Tables

Aprea AB, Key Information 4
Aprea AB, Key Facts 4
Aprea AB - Pipeline by Indication, 2013 6
Aprea AB - Pipeline by Stage of Development, 2013 7
Aprea AB - Monotherapy Products in Pipeline, 2013 8
Aprea AB - Phase I, 2013 9
Aprea AB - Discovery, 2013 10
Aprea AB - Pipeline By Therapeutic Class, 2013 14
Aprea AB - Pipeline By Target, 2013 15
Aprea AB - Pipeline By Route of Administration, 2013 16
Aprea AB - Pipeline By Mechanism of Action, 2013 17
Aprea AB - Recent Pipeline Updates, 2013 18
Aprea AB - Dormant Developmental Projects,2013 19



List of Figures

Aprea AB - Pipeline by Indication, 2013 6
Aprea AB - Pipeline by Stage of Development, 2013 7
Aprea AB - Monotherapy Products in Pipeline, 2013 8
Aprea AB - Pipeline By Route of Administration, 2013 16

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Inflammation - Pipeline Review, H1 2014

Inflammation - Pipeline Review, H1 2014

  • $ 2 500
  • Company report
  • June 2014
  • by Global Markets Direct

Inflammation - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Inflammation - Pipeline Review, H1 2014', provides an overview of the Inflammation's therapeutic pipeline. This report provides ...

Corcept Therapeutics Incorporated - Product Pipeline Review - 2014

Corcept Therapeutics Incorporated - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • April 2014
  • by Global Markets Direct

Corcept Therapeutics Incorporated - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Corcept Therapeutics Incorporated - Product Pipeline Review - 2014', provides an overview of the Corcept ...

Pharmaceutical in United States: ImmunoCellular Therapeutics, Ltd. – Product Pipeline Review – H2 2011

Pharmaceutical in United States: ImmunoCellular Therapeutics, Ltd. – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

- Product Pipeline Review - H2 2011” provides a detailed overview on the ImmunoCellular Therapeutics, Ltd.’s research and development focus. The report includes information on current developmental ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.